Valuation Abbott Laboratories Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
03:07:08 16/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 93.18 EUR | -0.38% |
|
+7.54% | -11.72% |
Company Valuation: Abbott Laboratories
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,41,365 | 1,91,427 | 1,91,088 | 1,96,184 | 2,17,859 | 1,81,137 | - | - |
| Change | - | -20.69% | -0.18% | 2.67% | 11.05% | -16.86% | - | - |
| Enterprise Value (EV) 1 | 2,49,166 | 1,98,318 | 1,98,871 | 2,02,693 | 2,22,266 | 2,05,076 | 2,02,094 | 1,98,403 |
| Change | - | -20.41% | 0.28% | 1.92% | 9.66% | -7.73% | -1.45% | -1.83% |
| P/E | 35.7x | 28.1x | 33.8x | 14.8x | 33.7x | 30.9x | 23.9x | 21x |
| PBR | 6.93x | 5.2x | 4.94x | 4.11x | 4.18x | 3.78x | 3.62x | 3.44x |
| PEG | - | -36.9x | -2x | 0x | -0.7x | -3.48x | 0.8x | 1.5x |
| Capitalization / Revenue | 5.6x | 4.39x | 4.76x | 4.68x | 4.91x | 3.61x | 3.32x | 3.11x |
| EV / Revenue | 5.78x | 4.54x | 4.96x | 4.83x | 5.01x | 4.09x | 3.71x | 3.41x |
| EV / EBITDA | 19.4x | 15.9x | 19.5x | 19.1x | 18.9x | 15.8x | 14x | 12.5x |
| EV / EBIT | 22x | 17.7x | 22.3x | 21.8x | 21.6x | 17.5x | 15.5x | 13.9x |
| EV / FCF | 28.8x | 25.4x | 39.3x | 31.9x | 30.1x | 27.2x | 22.7x | 20.7x |
| FCF Yield | 3.47% | 3.94% | 2.54% | 3.13% | 3.33% | 3.68% | 4.41% | 4.83% |
| Dividend per Share 2 | 1.82 | 1.92 | 2.08 | 2.24 | 2.4 | 2.57 | 2.741 | 2.898 |
| Rate of return | 1.29% | 1.75% | 1.89% | 1.98% | 1.92% | 2.46% | 2.62% | 2.77% |
| EPS 2 | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 | 3.389 | 4.374 | 4.986 |
| Distribution rate | 46.2% | 49.1% | 63.8% | 29.3% | 64.5% | 75.8% | 62.7% | 58.1% |
| Net sales 1 | 43,075 | 43,653 | 40,109 | 41,950 | 44,328 | 50,198 | 54,526 | 58,251 |
| EBITDA 1 | 12,815 | 12,485 | 10,188 | 10,635 | 11,735 | 12,986 | 14,468 | 15,892 |
| EBIT 1 | 11,324 | 11,231 | 8,911 | 9,295 | 10,301 | 11,722 | 13,020 | 14,317 |
| Net income 1 | 7,071 | 6,933 | 5,723 | 13,402 | 6,524 | 6,163 | 7,843 | 8,710 |
| Net Debt 1 | 7,801 | 6,891 | 7,783 | 6,509 | 4,407 | 23,939 | 20,957 | 17,267 |
| Reference price 2 | 140.74 | 109.79 | 110.07 | 113.11 | 125.29 | 104.68 | 104.68 | 104.68 |
| Nbr of stocks (in thousands) | 17,14,968 | 17,43,574 | 17,36,059 | 17,34,455 | 17,38,834 | 17,30,383 | - | - |
| Announcement Date | 26/01/22 | 25/01/23 | 24/01/24 | 22/01/25 | 22/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.89x | 4.09x | 15.79x | 2.46% | 18TCr | |
| 20.43x | 3.54x | 12.67x | 2.95% | 12TCr | |
| 22.83x | 4.47x | 15.61x | 1.23% | 11TCr | |
| 26.34x | 2.59x | 10.38x | 2.72% | 7.66TCr | |
| 18.73x | 0.22x | 13.57x | 0.7% | 6.52TCr | |
| 30.39x | 7.54x | 19.43x | 1.32% | 5.28TCr | |
| 37.34x | 3.56x | 12.2x | 2.02% | 5.28TCr | |
| 37.06x | 9.21x | 25.79x | -.--% | 4.31TCr | |
| 49.13x | 1.34x | 12.46x | 0.2% | 3.21TCr | |
| Average | 30.35x | 4.06x | 15.32x | 1.51% | 8.14TCr | |
| Weighted average by Cap. | 28.02x | 3.95x | 14.95x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Valuation Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
